柔肝灵颗粒联合恩替卡韦抗慢性乙型肝炎肝纤维化(气虚血瘀型)的临床研究.pdf

照组在临床研究过程中均未见明显不良反应的发生。 治疗组与对照组比较，治疗组改善临床症状，降低肝功、血清纤维化指标明显优于对 照组。两组治疗结束时病毒学应答比较，治疗组较对照组高。 关键词：临床研究；慢性乙型肝炎肝纤维化；柔肝灵颗粒；恩替卡韦 Rou-Gan-Ling KeLi United entecavir resistance of liver fibrosis in chronic hepatitis B patients affected observation Clinical Abstract Objective: to explore the Rou-Gan-Ling KeLi joint entecavir for chronic hepatitis B patients with clinical symptoms, serum fibrosis indices, hepatic function, HBeAg shade rate, HBV DNA load and B exceeds -- the influence. Methods